Real-World Analyses of the Treatment Conditions in Patients Initiating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitor in Taiwan
台湾地区接受前蛋白转化酶枯草杆菌蛋白酶/Kexin 9型(PCSK9)抑制剂治疗的患者的真实世界治疗情况分析
期刊:Journal of Atherosclerosis and Thrombosis
影响因子:2.8
doi:10.5551/jat.63789
Lin, Po-Lin; Wu, Yen-Wen; Lin, Chao-Feng; Yeh, Hung-I; Chang, Wei-Ting; Charng, Min-Ji; Huang, Po-Hsun; Lin, Chih-Chan; Lin, Tsung-Hsien; Lin, Wei-Wen; Hsieh, I-Chang; Kuo, Feng-Yu; Chen, Ching-Pei; Li, Yi-Heng